Loading...
HSChapter 30
U.S. imports of hormone & endocrine medicaments in dosage form (nesoi) (HS 300439) totaled $1.0B in July 2026, traded with 33 countries.
Importers of Hormone & Endocrine Medicaments in Dosage Form (NESOI) paid $536K in duties in July 2026 — an effective duty rate of 10% on $5.4M in dutiable value, based on actual customs collections rather than the published tariff schedule. Hormone & Endocrine Medicaments in Dosage Form (NESOI) imports of $1.0B in July 2026 ran 46% above the year-to-date monthly average of $690.0M.
Last updated: July 2026 dataFinished-dose hormone and endocrine medicaments not classified elsewhere — including epinephrine (3004390020), levothyroxine (3004390030), norepinephrine (3004390040), and vasopressin (3004390045) alongside veterinary hormone formulations and a residual NESOI category — span critical-care, thyroid, and emergency-medicine applications. Ireland and Germany lead US supply, with Switzerland, Denmark, and China also contributing, a mix that reflects both originator pharmaceutical manufacturing in Europe and generic production elsewhere. Epinephrine auto-injectors and vasopressin injectables have been subject to drug shortage designations, making supply-chain continuity a recurring concern for hospital formulary managers. FDA product approval and facility registration are required for all entries under this heading.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
882 shipments/mo
Combination products are generally classified by their essential character or by the active ingredient that drives the primary therapeutic action. If the hormone or endocrine substance is the principal active ingredient, classification under 300439 is appropriate. However, if the combination also contains an antibiotic, a different heading applies. For novel combinations, a CBP binding ruling is the most reliable path to correct classification.
Both epinephrine and vasopressin injectables have experienced recurring US drug shortages, partly due to manufacturing concentration and sterile injectable production complexity. Importers and hospital procurement teams should monitor FDA's drug shortage database and maintain visibility into their supplier's production capacity and FDA inspection history. A facility placed on import alert can disrupt supply with little warning, so qualifying backup suppliers in advance is advisable.
Supplier Network
Get discovered by U.S. importers searching for HS 300439 — Hormone & Endocrine Medicaments in Dosage Form (NESOI). Be the first supplier listed.
Subheading 2 of 12 in heading 3004
Subheading 300439 · $1.0B of $6.6B
ImportsExports
Imports
$1.0BYoY · Pro
Exports
$602.4MYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 3004390080 | Medicaments W/ Hormones or Products of 2937, NESOI | $968.6M | 0.05% | 0.52% | $504K |
| 3004390020 | Meds W/Hormones or Prdcts of 2937,Cont Epinephrine | $12.5M | 0.0052% | 0.05% | $643 |
| 3004390010 | Medicaments W/ Hormones or of 2937, Veterinary Use | $8.5M | 0.00% | 0.00% | -- |
| 3004390045 | Meds W/Hormones or Prdcts of 2937,Cont Vasopressin | $8.1M | 0.00% | 0.00% | -- |
| 3004390030 | Meds W/Hormnes/Prdcts of 2937,Cont Levothyroxine | $8.1M | 0.00% | 0.00% | -- |
| 3004390040 | Meds W/Hormnes/Prdcts of 2937,Cont Norepinephrine | $3.6M | 0.88% | 8.76% | $32K |
| 3004390015 | Containing Desmopressin Acetate | $1.3M | 0.00% | 0.00% | -- |
| 3004390050 | Medicaments W/ Hormones or Products of 2937, NESOI | $0 | -- | -- | -- |
| 3004390055 | Medicaments W/ Hormones or Products of 2937, NESOI | $0 | -- | -- | -- |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3004390050 | Medicaments W/ Hormones or Products of 2937, NESOI | $590.8M |
| 3004390010 | Medicaments W/ Hormones or of 2937, Veterinary Use | $11.6M |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
Imports · July 2026
origin
China and Ireland together supply 67% of it.
customs district
destination
entry
rate provision · imports
98.7% enters free of duty; the effective duty rate is 0.05%.